EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

KI17: A Bioinspired Peptide Derived from Talisia esculenta with In Vitro Anticancer and Immunomodulatory Activities

Ana Paula Ramos Pereira iD, Ana Cristina Jacobowski iD, Camila de Oliveira Gutierrez, Octávio Luiz Franco, Marlon Henrique Cardoso iD, Thaís de Andrade Farias Rodrigues iD, Rodrigo Juliano Oliveira iD, Priscila Aiko Hiane iD, Rita de Cássia Avellaneda Guimarães, Ana Paula de Araújo Boleti, Maria Lígia Rodrigues Macedo iD

Molecules · 2026

DOI: 10.3390/molecules31142434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Ana Paula Ramos Pereira und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Protein Purification and Biological Functions, FACFAN, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil. Hauptthemen laut MEDLINE: Antineoplastic Agents, Peptides, Immunologic Factors, Immunomodulating Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Conselho Nacional de Desenvolvimento Científico e Tecnológico, Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul, Financiadora de Estudos e Projetos.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer therapy remains limited by drug resistance and poor selectivity, while inflammation-driven tumor progression further complicates treatment outcomes. Antimicrobial peptides (AMPs) have emerged as promising therapeutic alternatives due to their multifunctional properties. In this study, we investigated the anticancer and immunomodulatory activities of KI17, a rationally designed peptide derived from GL18, a peptide fragment identified from the talisin protein of Talisia esculenta. KI17 exhibited dose-dependent antiproliferative effects against murine and human melanoma (B16F10-Nex2, SK-MEL-2, A375) and cervical cancer (HeLa) cell lines, while displaying reduced cytotoxicity toward non-tumoral BV-2 microglial cells, resulting in a favorable selectivity index. Mechanistic analyses revealed that KI17 induces morphological alterations, mitochondrial dysfunction, caspase activation, and late-stage apoptosis, together with G0/G1 cell cycle arrest accompanied by accumulation of the Sub-G0 population, indicating coordinated regulation of cell death and cell cycle progression. KI17 effectively suppressed lipopolysaccharide (LPS)-induced microglial activation, markedly reducing pro-inflammatory cytokine and nitric oxide production without compromising cell viability. These biological activities are consistent with the peptide’s optimized physicochemical features, including increased cationicity, amphipathicity, and α-helical folding. Overall, our findings demonstrate that KI17 combines selective anticancer activity with potent immunomodulatory effects, highlighting its potential as a bioinspired peptide for further preclinical development in cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsPeptidesImmunologic FactorsImmunomodulating AgentsHumansAnimalsMiceApoptosisCell Line, TumorCell ProliferationHeLa CellsCell SurvivalNitric Oxide

Stichwörter der Autor:innen

cell cycle arrestmelanomamitochondrial apoptosisrational peptide design

Substanzen

Antineoplastic AgentsPeptidesImmunologic FactorsImmunomodulating AgentsNitric Oxide

Autor:innen und Institutionen

  • Laboratory of Protein Purification and Biological Functions, FACFAN, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
  • S-Inova Biotech, Graduate Program in Biotechnology, Dom Bosco Catholic University, Campo Grande 79117-900, MS, Brazil.
  • Center for Proteomic and Biochemical Analysis, Graduate Program in Genomic Sciences and Biotechnology, Catholic University of Brasília, Brasília 71966-700, DF, Brazil.
  • Graduate Program in Environmental Sciences and Agricultural Sustainability, Dom Bosco Catholic University, Campo Grande 79117-900, MS, Brazil.
  • CeTroGen Laboratory, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.
  • Faculty of Pharmaceutical Sciences, Food and Nutrition, Universidade Federal de Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil.

ORCID-Profile: Ana Paula Ramos Pereira, Ana Cristina Jacobowski, Marlon Henrique Cardoso, Thaís de Andrade Farias Rodrigues, Rodrigo Juliano Oliveira, Priscila Aiko Hiane, Maria Lígia Rodrigues Macedo

Förderung

  • Conselho Nacional de Desenvolvimento Científico e Tecnológico
  • Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul
  • Financiadora de Estudos e Projetos
  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Pereira, A. P. R., Jacobowski, A. C., Gutierrez, C. O., Franco, O. L., Cardoso, M. H., Rodrigues, T. A. F., Oliveira, R. J., Hiane, P. A., Guimarães, R. C. A., Boleti, A. P. A., & Macedo, M. L. R. (2026). KI17: A Bioinspired Peptide Derived from Talisia esculenta with In Vitro Anticancer and Immunomodulatory Activities. Molecules. https://doi.org/10.3390/molecules31142434

Vancouver

Pereira APR, Jacobowski AC, Gutierrez CO, Franco OL, Cardoso MH, Rodrigues TAF, et al. KI17: A Bioinspired Peptide Derived from Talisia esculenta with In Vitro Anticancer and Immunomodulatory Activities. Molecules. 2026. doi:10.3390/molecules31142434

BibTeX
@article{Pereira2026,
  author = {Pereira, Ana Paula Ramos and Jacobowski, Ana Cristina and Gutierrez, Camila de Oliveira and Franco, Octávio Luiz and Cardoso, Marlon Henrique and Rodrigues, Thaís de Andrade Farias and Oliveira, Rodrigo Juliano and Hiane, Priscila Aiko and Guimarães, Rita de Cássia Avellaneda and Boleti, Ana Paula de Araújo and Macedo, Maria Lígia Rodrigues},
  title = {KI17: A Bioinspired Peptide Derived from Talisia esculenta with In Vitro Anticancer and Immunomodulatory Activities},
  journal = {Molecules},
  year = {2026},
  doi = {10.3390/molecules31142434}
}
Kostenlos starten →